MARK2 and carcinoma: The serine/threonine kinase, Akt, and its family members are amplified or their activity is constitutively elevated in human carcinomas such as breast, pancreatic, ovarian, brain, prostate and gastric tumours (Nicholson and Anderson, 2002).